For small or emerging biopharma companies, the key to business success extends well-beyond the quality of your molecule. To realize the full potential of your discovery, you need partners who can help you to anticipate and overcome financial, strategic and operational challenges throughout your development journey.
• How can you ensure you’ll have the cash flow to advance to your next milestone without delay?
• What are venture capitalists looking for when they evaluate potential biopharma investments?
• How do you ensure your outsourcing strategy will help you meet your business objectives?
• What partner strategies are the most successful biopharma companies using today?
Join Michel Lagarde, SVP and President of Pharma Services at Thermo Fisher Scientific (formerly Patheon), for a round table discussion about common challenges faced by small and emerging biopharma and the strategies to overcome them.
For more information please contact Isabel David at: firstname.lastname@example.org